Duloxetine for osteoarthritis fails to show superiority over conventional drugs

Coverage, in order

1. 7d ago
   
   Medical Tribune (JP) Japan indie ja

   Duloxetine for osteoarthritis fails to show superiority over conventional drugs変形性関節症へのデュロキセチン、従来薬に優越性示せず

   The SNRI duloxetine is an option for osteoarthritis pain, but guidelines rate it below NSAIDs and its benefit over or on top of conventional drugs is unclear, a Chinese study notes.セロトニン・ノルアドレナリン再取り込み阻害薬（SNRI）のデュロキセチンは、変形性関節症（OA）の疼痛に対する治療選択肢に挙げられるが、国内外のガイドラインにおける推奨度は、非ステロイド抗炎症薬（NSAID）などの従来薬と比べおおむね低く、従来薬と比較した有益性や既存治療への上乗せ効果は明らかでない。中国・Xi'an Jiaotong University Health Science Cente...

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.